AU Patent

AU2014201286B2 — Processes for the preparation of SGLT2 inhibitors

Assigned to Theracosbio LLC · Expires 2015-07-02 · 11y expired

What this patent protects

PROCESSES FOR THE PREPARATION OF SGLT2 Abstract Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose co transporter SGLT. The processes can reduce the number of steps needed to obtai…

USPTO Abstract

PROCESSES FOR THE PREPARATION OF SGLT2 Abstract Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose co transporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed in the processes are typically provided in a crystalline form. al vaiu M ~ R"R 2!'Ok k1 JOi-,r C, N P' .q "Z ------------------- F'F' sj

Drugs covered by this patent

Patent Metadata

Patent number
AU2014201286B2
Jurisdiction
AU
Classification
—
Expires
2015-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Theracosbio LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.